Drug Profile
Research programme: inflammation therapy - LION bioscience/Ono
Alternative Names: IL-10 synthesis inhibitors - LION bioscience/Ono; Interleukin-10 synthesis inhibitors - LION bioscience/OnoLatest Information Update: 01 Dec 2003
Price :
$50
*
At a glance
- Originator Ono Pharmaceutical; SYGNIS Pharma
- Class
- Mechanism of Action Interleukin 10 modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Inflammation
Most Recent Events
- 31 Dec 2002 Discontinued - Preclinical for Inflammation in USA (unspecified route)
- 11 Apr 2001 Trega Biosciences has been acquired by LION bioscience
- 18 Apr 2000 Preclinical development for Inflammation in USA (unspecified route)